These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24075627)

  • 1. [Clinical and biological efficacy of tocilizumab in giant cell arteritis: report of three patients and literature review].
    Kieffer P; Hinschberger O; Ciobanu E; Jaeger-Bizet F; Drabo A; Mostoufizadeh T; Martzolff L
    Rev Med Interne; 2014 Jan; 35(1):56-9. PubMed ID: 24075627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab in Giant Cell Arteritis.
    Mariano VJ; Frishman WH
    Cardiol Rev; 2018; 26(6):321-330. PubMed ID: 29570475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerance of tocilizumab for corticosteroid sparing in giant cell arteritis and aortitis: Experience of Nimes University Hospital about eleven patients].
    Broner J; Arnaud E
    Rev Med Interne; 2018 Feb; 39(2):78-83. PubMed ID: 29221884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab in the treatment of giant cell arteritis.
    Leuchten N; Aringer M
    Immunotherapy; 2018 Mar; 10(6):465-472. PubMed ID: 29504436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.
    Sakai R; Kondo T; Kurasawa T; Nishi E; Okuyama A; Chino K; Shibata A; Okada Y; Takei H; Nagasawa H; Amano K
    Clin Rheumatol; 2017 Oct; 36(10):2383-2392. PubMed ID: 28733791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab in Giant Cell Arteritis: A Multicenter Retrospective Study of 34 Patients.
    Régent A; Redeker S; Deroux A; Kieffer P; Ly KH; Dougados M; Liozon E; Larroche C; Guillevin L; Bouillet L; Espitia O; Costedoat-Chalumeau N; Soubrier M; Brihaye B; Lifermann F; Lefevre G; Puéchal X; Mouthon L; Toussirot E;
    J Rheumatol; 2016 Aug; 43(8):1547-52. PubMed ID: 27182063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tocilizumab for giant cell arteritis with corticosteroid-resistant progressive anterior ischemic optic neuropathy.
    Vionnet J; Buss G; Mayer C; Sokolov AA; Borruat FX; Spertini F
    Joint Bone Spine; 2017 Oct; 84(5):615-619. PubMed ID: 28499892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tocilizumab in refractory giant cell arteritis.
    Vinit J; Bielefeld P; Muller G; Besancenot JF
    Joint Bone Spine; 2012 May; 79(3):317-8. PubMed ID: 22284606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocilizumab for the treatment of giant cell arteritis.
    Schirmer M; Muratore F; Salvarani C
    Expert Rev Clin Immunol; 2018 May; 14(5):339-349. PubMed ID: 29676602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant cell arteritis: An updated review of an old disease.
    Rinden T; Miller E; Nasr R
    Cleve Clin J Med; 2019 Jul; 86(7):465-472. PubMed ID: 31291180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Does tocilizumab mean the end of glucocorticoids in giant cell arteritis?].
    Samson M; Bonnotte B
    Rev Med Interne; 2018 Feb; 39(2):75-77. PubMed ID: 29217104
    [No Abstract]   [Full Text] [Related]  

  • 13. Giant Cell Arteritis: Beyond Corticosteroids.
    Steel L; Khan A; Dasgupta B
    Drugs Aging; 2015 Aug; 32(8):591-9. PubMed ID: 26239828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Tocilizumab Be Used Routinely in New Patients With a Diagnosis of Giant Cell Arteritis?
    Sadun A; Gordon L
    J Neuroophthalmol; 2020 Mar; 40(1):117-121. PubMed ID: 31834197
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
    Loricera J; Blanco R; Hernández JL; Castañeda S; Mera A; Pérez-Pampín E; Peiró E; Humbría A; Calvo-Alén J; Aurrecoechea E; Narváez J; Sánchez-Andrade A; Vela P; Díez E; Mata C; Lluch P; Moll C; Hernández Í; Calvo-Río V; Ortiz-Sanjuán F; González-Vela C; Pina T; González-Gay MÁ
    Semin Arthritis Rheum; 2015 Jun; 44(6):717-23. PubMed ID: 25697557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Giant-cell arteritis with initial resistance to corticosteroids (author's transl)].
    Treves R; Gerbaud A; Catanzano G; Desproges-Gotteron R
    Sem Hop; 1982 Jan; 58(1):13-5. PubMed ID: 6275541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab for giant cell arteritis: an amazing result.
    Işık M; Kılıç L; Doğan İ; Calgüneri M
    Rheumatol Int; 2013 Nov; 33(11):2961-2. PubMed ID: 22965672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tongue necrosis secondary to giant cell arteritis, successfully treated with tocilizumab: a case report.
    Cho YM; El Khoury L; Paramo J; Horowitz DM; Li JY; Kello N
    BMC Musculoskelet Disord; 2023 May; 24(1):382. PubMed ID: 37189114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice.
    Calderón-Goercke M; Loricera J; Aldasoro V; Castañeda S; Villa I; Humbría A; Moriano C; Romero-Yuste S; Narváez J; Gómez-Arango C; Pérez-Pampín E; Melero R; Becerra-Fernández E; Revenga M; Álvarez-Rivas N; Galisteo C; Sivera F; Olivé-Marqués A; Álvarez Del Buergo M; Marena-Rojas L; Fernández-López C; Navarro F; Raya E; Galindez-Agirregoikoa E; Arca B; Solans-Laqué R; Conesa A; Hidalgo C; Vázquez C; Román-Ivorra JA; Lluch P; Manrique-Arija S; Vela P; De Miguel E; Torres-Martín C; Nieto JC; Ordas-Calvo C; Salgado-Pérez E; Luna-Gomez C; Toyos-Sáenz de Miera FJ; Fernández-Llanio N; García A; Larena C; Palmou-Fontana N; Calvo-Río V; Prieto-Peña D; González-Vela C; Corrales A; Varela-García M; Aurrecoechea E; Dos Santos R; García-Manzanares Á; Ortego N; Fernández S; Ortiz-Sanjuán F; Corteguera M; Hernández JL; González-Gay MÁ; Blanco R
    Semin Arthritis Rheum; 2019 Aug; 49(1):126-135. PubMed ID: 30655091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cost-Effectiveness of Tocilizumab (Actemra) Therapy in Giant Cell Arteritis.
    Jogimahanti AV; Kini AT; Irwin LE; Lee AG
    J Neuroophthalmol; 2021 Sep; 41(3):342-350. PubMed ID: 34415267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.